vs
Concrete Pumping Holdings, Inc.（BBCP）とMESA LABORATORIES INC（MLAB）の財務データ比較。上の社名をクリックして会社を切り替えられます
Concrete Pumping Holdings, Inc.の直近四半期売上が大きい（$98.9M vs $65.1M、MESA LABORATORIES INCの約1.5倍）。MESA LABORATORIES INCの純利益率が高く（5.6% vs 5.4%、差は0.2%）。MESA LABORATORIES INCの前年同期比売上増加率が高い（3.6% vs -3.2%）。MESA LABORATORIES INCの直近四半期フリーキャッシュフローが多い（$18.0M vs $1.9M）。過去8四半期でMESA LABORATORIES INCの売上複合成長率が高い（5.1% vs 4.8%）
コンクリートポンピングホールディングス社は、米国と英国を中心にコンクリートポンプサービスおよび関連機器のレンタルを提供する大手企業です。インフラ工事、商業不動産開発、住宅建設などの分野で、効率的かつ安全なコンクリート打設を支援しています。
メサラボラトリーズ社は、品質管理、校正、モニタリング向け専門機器及び関連サービスの開発・製造・販売を事業としています。医療、製薬、食品飲料、産業衛生、環境試験分野を中心に、世界中の顧客の規制遵守と運用安全のニーズに応えています。
BBCP vs MLAB — 直接比較
損益計算書 — Q4 FY2025 vs Q3 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $98.9M | $65.1M |
| 純利益 | $5.3M | $3.6M |
| 粗利率 | 43.8% | 64.2% |
| 営業利益率 | 17.0% | 12.2% |
| 純利益率 | 5.4% | 5.6% |
| 売上前年比 | -3.2% | 3.6% |
| 純利益前年比 | -43.6% | 316.6% |
| EPS（希薄化後） | $0.09 | $0.65 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $98.9M | $65.1M | ||
| Q3 25 | $94.2M | $60.7M | ||
| Q2 25 | $85.2M | $59.5M | ||
| Q1 25 | $78.0M | $62.1M | ||
| Q4 24 | $102.1M | $62.8M | ||
| Q3 24 | $100.6M | $57.8M | ||
| Q2 24 | $98.7M | $58.2M | ||
| Q1 24 | $90.0M | $58.9M |
| Q4 25 | $5.3M | $3.6M | ||
| Q3 25 | $3.7M | $2.5M | ||
| Q2 25 | $-4.0K | $4.7M | ||
| Q1 25 | $-2.6M | $-7.1M | ||
| Q4 24 | $9.4M | $-1.7M | ||
| Q3 24 | $7.6M | $3.4M | ||
| Q2 24 | $3.0M | $3.4M | ||
| Q1 24 | $-3.8M | $-254.6M |
| Q4 25 | 43.8% | 64.2% | ||
| Q3 25 | 42.9% | 61.5% | ||
| Q2 25 | 42.5% | 62.0% | ||
| Q1 25 | 40.0% | 61.8% | ||
| Q4 24 | 45.3% | 63.3% | ||
| Q3 24 | 44.3% | 61.3% | ||
| Q2 24 | 42.3% | 64.0% | ||
| Q1 24 | 37.0% | 62.1% |
| Q4 25 | 17.0% | 12.2% | ||
| Q3 25 | 13.7% | 7.8% | ||
| Q2 25 | 9.7% | 5.1% | ||
| Q1 25 | 4.5% | 2.4% | ||
| Q4 24 | 18.8% | 9.2% | ||
| Q3 24 | 16.5% | 6.1% | ||
| Q2 24 | 12.2% | 9.6% | ||
| Q1 24 | 1.6% | -460.6% |
| Q4 25 | 5.4% | 5.6% | ||
| Q3 25 | 3.9% | 4.1% | ||
| Q2 25 | -0.0% | 8.0% | ||
| Q1 25 | -3.4% | -11.4% | ||
| Q4 24 | 9.2% | -2.7% | ||
| Q3 24 | 7.5% | 5.9% | ||
| Q2 24 | 3.1% | 5.8% | ||
| Q1 24 | -4.3% | -432.2% |
| Q4 25 | $0.09 | $0.65 | ||
| Q3 25 | $0.07 | $0.45 | ||
| Q2 25 | $-0.01 | $0.85 | ||
| Q1 25 | $-0.06 | $-1.30 | ||
| Q4 24 | $0.16 | $-0.31 | ||
| Q3 24 | $0.13 | $0.63 | ||
| Q2 24 | $0.05 | $0.62 | ||
| Q1 24 | $-0.08 | $-47.26 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $44.4M | $29.0M |
| 総負債低いほど良い | $417.9M | $68.4M |
| 株主資本純資産 | $264.8M | $186.7M |
| 総資産 | $879.5M | $434.8M |
| 負債/資本比率低いほどレバレッジが低い | 1.58× | 0.37× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $44.4M | $29.0M | ||
| Q3 25 | $41.0M | $20.4M | ||
| Q2 25 | $37.8M | $21.3M | ||
| Q1 25 | $85.1M | $27.3M | ||
| Q4 24 | $43.0M | $27.3M | ||
| Q3 24 | $26.3M | $24.3M | ||
| Q2 24 | $18.0M | $28.5M | ||
| Q1 24 | $14.7M | $28.2M |
| Q4 25 | $417.9M | $68.4M | ||
| Q3 25 | $417.6M | $69.4M | ||
| Q2 25 | $417.3M | $70.3M | ||
| Q1 25 | $417.1M | $71.3M | ||
| Q4 24 | $373.3M | $72.2M | ||
| Q3 24 | $372.9M | $73.1M | ||
| Q2 24 | $372.6M | $74.1M | ||
| Q1 24 | $372.2M | — |
| Q4 25 | $264.8M | $186.7M | ||
| Q3 25 | $261.3M | $178.5M | ||
| Q2 25 | $261.8M | $172.5M | ||
| Q1 25 | $260.7M | $159.8M | ||
| Q4 24 | $321.7M | $155.2M | ||
| Q3 24 | $314.7M | $161.5M | ||
| Q2 24 | $308.3M | $150.7M | ||
| Q1 24 | $307.9M | $145.4M |
| Q4 25 | $879.5M | $434.8M | ||
| Q3 25 | $886.0M | $430.4M | ||
| Q2 25 | $878.8M | $435.7M | ||
| Q1 25 | $912.9M | $433.3M | ||
| Q4 24 | $898.0M | $433.3M | ||
| Q3 24 | $890.8M | $454.1M | ||
| Q2 24 | $894.7M | $440.4M | ||
| Q1 24 | $894.8M | $446.8M |
| Q4 25 | 1.58× | 0.37× | ||
| Q3 25 | 1.60× | 0.39× | ||
| Q2 25 | 1.59× | 0.41× | ||
| Q1 25 | 1.60× | 0.45× | ||
| Q4 24 | 1.16× | 0.47× | ||
| Q3 24 | 1.19× | 0.45× | ||
| Q2 24 | 1.21× | 0.49× | ||
| Q1 24 | 1.21× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $14.5M | $18.8M |
| フリーキャッシュフロー営業CF - 設備投資 | $1.9M | $18.0M |
| FCFマージンFCF / 売上 | 1.9% | 27.7% |
| 設備投資強度設備投資 / 売上 | 12.7% | 1.1% |
| キャッシュ転換率営業CF / 純利益 | 2.72× | 5.17× |
| 直近12ヶ月FCF直近4四半期 | $17.5M | $37.9M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $14.5M | $18.8M | ||
| Q3 25 | $19.1M | $8.2M | ||
| Q2 25 | $24.7M | $1.9M | ||
| Q1 25 | $6.0M | $12.7M | ||
| Q4 24 | $22.4M | $18.1M | ||
| Q3 24 | $35.0M | $5.3M | ||
| Q2 24 | $9.1M | $10.7M | ||
| Q1 24 | $20.3M | $12.9M |
| Q4 25 | $1.9M | $18.0M | ||
| Q3 25 | $4.3M | $7.1M | ||
| Q2 25 | $11.1M | $884.0K | ||
| Q1 25 | $191.0K | $11.9M | ||
| Q4 24 | $16.1M | $17.3M | ||
| Q3 24 | $26.4M | $3.5M | ||
| Q2 24 | $-1.9M | $9.9M | ||
| Q1 24 | $2.5M | $12.3M |
| Q4 25 | 1.9% | 27.7% | ||
| Q3 25 | 4.6% | 11.7% | ||
| Q2 25 | 13.0% | 1.5% | ||
| Q1 25 | 0.2% | 19.2% | ||
| Q4 24 | 15.8% | 27.6% | ||
| Q3 24 | 26.2% | 6.0% | ||
| Q2 24 | -1.9% | 16.9% | ||
| Q1 24 | 2.8% | 21.0% |
| Q4 25 | 12.7% | 1.1% | ||
| Q3 25 | 15.7% | 1.8% | ||
| Q2 25 | 16.0% | 1.7% | ||
| Q1 25 | 7.5% | 1.2% | ||
| Q4 24 | 6.2% | 1.3% | ||
| Q3 24 | 8.6% | 3.1% | ||
| Q2 24 | 11.2% | 1.5% | ||
| Q1 24 | 19.7% | 0.9% |
| Q4 25 | 2.72× | 5.17× | ||
| Q3 25 | 5.16× | 3.32× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.38× | — | ||
| Q3 24 | 4.63× | 1.54× | ||
| Q2 24 | 3.00× | 3.17× | ||
| Q1 24 | — | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
BBCP
| US Concrete Pumping | $72.2M | 73% |
| US Concrete Waste Management Services | $21.3M | 22% |
| Other | $5.4M | 5% |
MLAB
| Sterilization And Disinfection Control | $24.9M | 38% |
| Biopharmaceutical Development | $14.4M | 22% |
| Other | $14.1M | 22% |
| Clinical Genomics | $11.8M | 18% |
